Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 102524501000001116 | Saxagliptin + Dapagliflozin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 102524601000001117 | Saxagliptin + Dapagliflozin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Saxagliptin + Dapagliflozin | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Saxagliptin + Dapagliflozin | Is a | Product containing saxagliptin | false | Inferred relationship | Existential restriction modifier | ||
| Saxagliptin + Dapagliflozin | Is a | Product containing dapagliflozin | false | Inferred relationship | Existential restriction modifier | ||
| Saxagliptin + Dapagliflozin | Has active ingredient | Saxagliptin | true | Inferred relationship | Existential restriction modifier | ||
| Saxagliptin + Dapagliflozin | Has active ingredient | Dapagliflozin | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Saxagliptin 5mg / Dapagliflozin 10mg tablets | Is a | True | Saxagliptin + Dapagliflozin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR